DoD Anthrax Vaccine Program May Need Second Manufacturer, Senators Say

The Department of Defense should consider recruiting a second anthrax vaccine manufacturer to compensate for continued delays experienced by Bioport, Sen. Roberts (R-Kan.) indicated during a Senate Armed Services Committee hearing April 13.